Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Peugeot Invest	FFP	4. oct 2024	74.60	+0.54
PEXA AB SER.B	FA0	4. oct 2024	0.03	0.00
Pexip Holding	4W9	4. oct 2024	3.19	+1.27
Peyto Exploration & Development Corp.	PXK	4. oct 2024	10.65	-0.37
Pfeiffer Vacuum Technology AG	PFV	4. oct 2024	154.00	-0.52
Pferdewetten.de AG	EMH	4. oct 2024	6.40	-3.03
PFERDEWETTEN.DE NA NEUE	EMH0	4. oct 2024	4.70	0.00
PFIZER INC.CDR REG.S	PFEB	4. oct 2024	8.55	-1.16
Pfizer, Inc.	PFE	4. oct 2024	25.98	+1.19
PGE Polska Grupa Energetyczna SA	6PG	4. oct 2024	1.60	-0.62
PHARMACOLOG I UPPSALA B	P750	4. oct 2024	0.01	0.00
Pharmamar S.A.	PMRA	4. oct 2024	46.78	+1.21
Pharmanutra S.p.A.	761	4. oct 2024	54.60	-0.91
Pharmaron Beijing Co Ltd	17Q1	4. oct 2024	2.06	+13.19
PHARMASGP HOLDING SE O.N.	PSG	4. oct 2024	22.20	+1.83
Pharmaust Ltd.	ECQ	4. oct 2024	0.09	+3.41
Pharming Group N.V. - ADS, each representing 10 ordinary sha	PHG	4. oct 2024	7.05	+1.44
Pharming Group NV	PHGN	4. oct 2024	0.72	-0.96
PHarol SGPS SA	PTCA	4. oct 2024	0.04	+0.46
Pharos Energy Plc	OCS1	4. oct 2024	0.28	-2.11
Pharvaris N.V. - Ordinary Shares	9EN	4. oct 2024	15.90	0.00
PHASE HOLO.IMAG.PHI SK-20	L5W	4. oct 2024	0.40	-1.49
PHAXIAM THERAPEUT. EO 1,-	2E40	4. oct 2024	1.80	+3.57
PHC Holdings Corporation	2GY	4. oct 2024	6.40	-0.78
PhenixFIN	Q29	4. oct 2024	42.40	+0.95
Phenom Resources Corp	1PY0	4. oct 2024	0.25	-2.33
Phibro Animal Health Corporation - Class A	PB8	4. oct 2024	18.90	-3.08
Phicomm AG	HBD1	4. oct 2024	0.60	0.00
Philion Se Bearer NPV	PH6	4. oct 2024	0.43	0.00
Philip Morris Cr A.S.	TBK	4. oct 2024	601.00	+0.50

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.